{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:32:44Z","timestamp":1789471964953,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008908","name":"Universit\u00e0 degli Studi di Messina","doi-asserted-by":"publisher","award":["98122"],"award-info":[{"award-number":["98122"]}],"id":[{"id":"10.13039\/501100008908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.diabres.2025.112117","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T23:19:42Z","timestamp":1742685582000},"page":"112117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Tips for successful use of commercial automated insulin delivery systems: An expert paper of the Italian working group on diabetes and technology"],"prefix":"10.1016","volume":"223","author":[{"given":"Sergio","family":"Di Molfetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Assaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Grancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Guardasole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-8515","authenticated-orcid":false,"given":"Andrea Enzo","family":"Scaramuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta Maria","family":"Scarpitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zanfardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Avogaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Irace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112117_b0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2025.112117_b0010","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2025.112117_b0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.diabres.2025.112117_b0020","doi-asserted-by":"crossref","first-page":"e3842","DOI":"10.1002\/dmrr.3842","article-title":"Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis","volume":"40","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"10.1016\/j.diabres.2025.112117_b0025","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.2337\/dc24-1550","article-title":"Efficacy and safety of a tubeless AID system compared with pump therapy with CGM in the treatment of type 1 diabetes in adults with suboptimal glycemia: a randomized parallel-group clinical trial","volume":"47","author":"Renard","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112117_b0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1932296820986879","article-title":"The impact of a recently approved automated insulin delivery system on glycemic, sleep, and psychosocial outcomes in older adults with type 1 diabetes: a pilot study","volume":"16","author":"Bisio","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112117_b0035","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2025.112117_b0040","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.2337\/dc24-S007","article-title":"7. Diabetes Technology: Standards of Care in Diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care."},{"issue":"38","key":"10.1016\/j.diabres.2025.112117_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pdi.2350","article-title":"Closed-loop technology: a practical guide","volume":"2","author":"Hartnell","year":"2021","journal-title":"Pract Diab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1932296820955168","article-title":"Training and support for hybrid closed-loop therapy","volume":"16","author":"Boughton","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-022-05744-z","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. a consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association","volume":"66","author":"Sherr","year":"2023","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2025.112117_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.10.004","article-title":"SFD SFD Paramedical SFE SFEDP AJD FFD FENAREDIAM and CNP-EDN. Practical implementation of automated closed-loop insulin delivery: A French position statement","volume":"47","author":"Tubiana-Rufi","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2025.112117_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pdi.2350","article-title":"Closed-loop technology: a practical guide","volume":"38","author":"Hartnell","year":"2021","journal-title":"Pract Diab"},{"issue":"3","key":"10.1016\/j.diabres.2025.112117_b0070","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/dc22-1692","article-title":"Simplified meal announcement versus precise carbohydrate counting in adolescents with type 1 diabetes using the mini med 780G advanced hybrid closed loop system: a randomized controlled trial comparing glucose control","volume":"46","author":"Petrovski","year":"2023","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2025.112117_b0075","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.2337\/dc20-1560","article-title":"Lower daily carbohydrate intake is associated with improved glycemic control in adults with type 1 diabetes using a hybrid closed-loop system","volume":"43","author":"Lehmann","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00125-021-05587-0","article-title":"Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system","volume":"65","author":"Vetrani","year":"2022","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.diabres.2025.112117_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108689","article-title":"Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies","volume":"38","author":"Annuzzi","year":"2024","journal-title":"J Diabetes Complications"},{"issue":"12","key":"10.1016\/j.diabres.2025.112117_b0090","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/dme.14116","article-title":"The importance of prandial insulin bolus timing with hybrid closed-loop systems","volume":"36","author":"Boughton","year":"2019","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4093\/dmj.2022.0035","article-title":"Performance of fast-acting aspart insulin as compared to aspart insulin in insulin pump for managing type 1 diabetes mellitus: a meta-analysis","volume":"47","author":"Dutta","year":"2023","journal-title":"Diab Metab J"},{"issue":"11","key":"10.1016\/j.diabres.2025.112117_b0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/17434440.2022.2142556","article-title":"Closed-loop insulin delivery: update on the state of the field and emerging technologies","volume":"19","author":"Ware","year":"2022","journal-title":"Expert Rev Med Devices"},{"issue":"4","key":"10.1016\/j.diabres.2025.112117_b0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc17-1682","article-title":"Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the Mini Med 670G system","volume":"41","author":"Messer","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2025.112117_b0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/dia.2020.0472","article-title":"Clinical management and pump parameter adjustment of the control-IQ closed-loop control system: results from a 6-month multicenter randomized clinical trial","volume":"23","author":"O'Malley","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0115","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2589-7500(19)30003-2","article-title":"DIABELOOP WP7 Trial Investigators. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial","volume":"1","author":"Benhamou","year":"2019","journal-title":"Lancet Digit Health"},{"issue":"6","key":"10.1016\/j.diabres.2025.112117_b0120","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2337\/dc15-0100","article-title":"Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era","volume":"38","author":"Bell","year":"2015","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2025.112117_b0125","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jdiacomp.2017.08.014","article-title":"T1D Exchange clinic network. reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D exchange clinic registry","volume":"31","author":"Aleppo","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"6","key":"10.1016\/j.diabres.2025.112117_b0130","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/19322968211035447","article-title":"Hybrid closed-loop to manage gastroparesis in people with type 1 diabetes: a case series","volume":"15","author":"Daly","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2025.112117_b0135","unstructured":"Care TD. t:slim X2 Insulin pump with Control-IQ Technology. User Guide. Accessed September 9, 2024. https:\/\/www.tandemdiabetes.com\/docs\/default-source\/product-documents\/t-slim-x2-insulin-pump\/aw-1006230_b_user-guide-tslim-x2-control-iq-7-4-mmoll-eng-international-artwork4cfb729775426a79a519ff0d00a9fd39.pdf?sfvrsn=18a507d7_127."},{"key":"10.1016\/j.diabres.2025.112117_b0140","unstructured":"CamAPS FX User Manual. Accessed September 9, 2024. https:\/\/s3-eu-west-1.amazonaws.com\/camdiab.user.manual\/user_manual_fx_mmoll_commercial.pdf."},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/dia.2024.0298","article-title":"Safety of options to \u201cboost\u201d (enhancing insulin infusion rates) and \u201cease-off\u201d (reducing insulin infusion rates) in CamAPS FX hybrid closed-loop system: a real-world analysis","volume":"27","author":"Royston","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.diabres.2025.112117_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15078","article-title":"UK's association of british clinical diabetologists' diabetes technology network (ABCD-DTN): best practice guide for hybrid closed-loop therapy","volume":"40","author":"Griffin","year":"2023","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.diabres.2025.112117_b0155","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/dme.13011","article-title":"Influence of dietary protein on postprandial blood glucose levels in individuals with type 1 diabetes mellitus using intensive insulin therapy","volume":"33","author":"Paterson","year":"2016","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.diabres.2025.112117_b0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/dia.2012.0149","article-title":"Should the amounts of fat and protein be taken into consideration to calculate the lunch prandial insulin bolus? Results from a randomized crossover trial","volume":"15","author":"Garc\u00eda-L\u00f3pez","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.diabres.2025.112117_b0165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1399-5448.2012.00880.x","article-title":"Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy","volume":"13","author":"Kordonouri","year":"2012","journal-title":"Pediatr Diab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/dia.2011.0083","article-title":"Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study","volume":"14","author":"Pa\u0144kowska","year":"2012","journal-title":"Diab Technol Ther"},{"issue":"4","key":"10.1016\/j.diabres.2025.112117_b0175","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/dc12-0092","article-title":"Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management","volume":"36","author":"Wolpert","year":"2013","journal-title":"Diab Care"},{"issue":"11","key":"10.1016\/j.diabres.2025.112117_b0180","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/dom.14807","article-title":"Predictors of time in target glucose range in real-world users of the MiniMed 780G system","volume":"24","author":"Casta\u00f1eda","year":"2022","journal-title":"Diab Obes Metab"},{"issue":"12","key":"10.1016\/j.diabres.2025.112117_b0185","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/dia.2023.0308","article-title":"Therapy settings associated with optimal outcomes for t:slim x2 with Control-IQ technology in real-world clinical care","volume":"25","author":"Messer","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"Supplement_1","key":"10.1016\/j.diabres.2025.112117_b0190","doi-asserted-by":"crossref","DOI":"10.2337\/db23-278-OR","article-title":"278-OR: impact of a parameter change in DBLG1 system","volume":"72","author":"Adenis","year":"2023","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.diabres.2025.112117_b0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2021.0097","article-title":"One year real-world use of the Control-IQ advanced hybrid closed-loop technology","volume":"23","author":"Breton","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"13","key":"10.1016\/j.diabres.2025.112117_b0200","article-title":"To sleep or not to sleep: an Italian Control-IQ-uestion","volume":"12","author":"Bassi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.diabres.2025.112117_b0205","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2337\/dc22-1721","article-title":"T1DEXI Study Group. Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI)","volume":"46","author":"Riddell","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2025.112117_b0210","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/19322968221088327","article-title":"Strengths and challenges of closed-loop insulin delivery during exercise in people with type 1 diabetes: potential future directions","volume":"17","author":"Paldus","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"10.1016\/j.diabres.2025.112117_b0215","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1210\/jc.2012-1604","article-title":"The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus","volume":"97","author":"Fahey","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.diabres.2025.112117_b0220","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/s21020479","article-title":"A comprehensive review of continuous glucose monitoring accuracy during exercise periods","volume":"21","author":"Mu\u00f1oz Fabra","year":"2021","journal-title":"Sensors (Basel)"},{"issue":"5","key":"10.1016\/j.diabres.2025.112117_b0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-8587(17)30014-1","article-title":"Exercise management in type 1 diabetes: a consensus statement","volume":"5","author":"Riddell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.diabres.2025.112117_b0230","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/19322968211035110","article-title":"First randomized controlled trial of hybrid closed loop versus multiple daily injections or insulin pump using self-monitoring of blood glucose in free-living adults with type 1 diabetes undertaking exercise","volume":"15","author":"Paldus","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"10.1016\/j.diabres.2025.112117_b0235","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.2337\/dc13-0010","article-title":"Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes","volume":"36","author":"Sherr","year":"2013","journal-title":"Diab Care"},{"issue":"2","key":"10.1016\/j.diabres.2025.112117_b0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00125-024-06308-z","article-title":"The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)","volume":"68","author":"Moser","year":"2025","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.diabres.2025.112117_b0245","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jcjd.2020.06.003","article-title":"Glucose control during physical activity and exercise using closed-loop technology in adults and adolescents with type 1 diabetes","volume":"44","author":"Zaharieva","year":"2020","journal-title":"Can J Diabetes"},{"issue":"S3","key":"10.1016\/j.diabres.2025.112117_b0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/dia.2023.0420","article-title":"Exercising safely with the MiniMed\u2122 780G automated insulin delivery system","volume":"26","author":"O'Neal","year":"2024","journal-title":"Diab Technol Ther"},{"issue":"1","key":"10.1016\/j.diabres.2025.112117_b0255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/dc21-1593","article-title":"A randomized crossover trial comparing glucose control during moderate-intensity, high-intensity, and resistance exercise with hybrid closed-loop insulin delivery while profiling potential additional signals in adults with type 1 diabetes","volume":"45","author":"Paldus","year":"2022","journal-title":"Diab Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725001317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725001317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:41:52Z","timestamp":1762260112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725001317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":51,"alternative-id":["S0168822725001317"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112117","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tips for successful use of commercial automated insulin delivery systems: An expert paper of the Italian working group on diabetes and technology","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112117"}}